Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer-Reference-Cited by-同舟云学术

Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer

Published:2001-02-11 Issue:1 Volume:37 Page:38-43
ISSN:1034-4810
Container-title:Journal of Paediatrics and Child Health
language:en
Short-container-title:J Paediatr Child Health

Author:

Ariffin H,Arasu A,Mahfuzah M,Ariffin WA,Chan LL,Lin HP

Publisher

Wiley

Subject

Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1754.2001.00585.x/fullpdf

Reference31 articles.

1. Overview of Empiric Antibiotic Therapy for the Febrile Neutropenic Patient

2. Fever, neutropenia and malignancy: A clinical syndrome in evolution

3. Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with Cancer

4. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia;PLOS ONE;2024-02-01

2. Association of ideal cardiovascular health metrics with incident low estimated glomerular filtration rate: More than a decade follow-up in the Tehran Lipid and Glucose Study (TLGS);PLOS ONE;2024-02-01

3. Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection;BMC Infectious Diseases;2017-09-25

4. Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging;Cancer;2017-06-27

5. Clinical analysis of combination therapy for febrile neutropenic patients in childhood cancer;Pediatrics International;2013-02